In summary, administration of hypo-SF-MSCs further ameliorates renal fibrosis in IRI rats compared with normo-SF-MSCs with evidence that hypoxic preconditioning enhances the ability of SF-MSCs to inhibit the TGF-β/Smad signaling pathway. This evidence concerns the gene TGFB1 and renal fibrosis.